Mar 07, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 07, 2016 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
Aehr Test Systems to Exhibit at Burn-in and Test Strategies Workshop in Mesa, AZ March 6-9
Mar 07, 2016 12:30 pm UTC| Business
FREMONT, Calif., March 07, 2016 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will exhibit in Booth A28 at the 17th annual Burn-in and Test...
Spark Therapeutics Announces Acquisition of Genable Technologies
Mar 07, 2016 12:20 pm UTC| Business
PHILADELPHIA, March 07, 2016 -- Spark Therapeutics (NASDAQ:ONCE) today announced that it has acquired Dublin, Ireland-based Genable Technologies, a private gene therapy innovator with which Spark has collaborated since...
Galena Biopharma to Present at the 28th Annual ROTH Conference
Mar 07, 2016 12:05 pm UTC| Business
SAN RAMON, Calif., March 07, 2016 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet...
Mar 07, 2016 12:05 pm UTC| Business
PRINCETON, N.J., March 07, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced dose administration for the first patient in the expansion phase...
Mar 07, 2016 12:05 pm UTC| Business
- MAT2501 (encochleated amikacin) previously designated a Qualified Infectious Disease Product by FDA - - MAT2501 demonstrated oral bioavailability and targeted delivery directly to site of non-tuberculous mycobacteria...
Mar 07, 2016 12:00 pm UTC| Business
OXFORD, United Kingdom, March 07, 2016 -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile...